Clinical Trial

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benefits of lung cancer screening by providing a blue print of best practices for screening sites to deliver tobacco treatment to their patients who are smokers, in a way that does not add burden to screening site staff and increases the chances of patients quitting smoking.
Protocol Amendment History 41 amendments
This ClinicalTrials.gov record has been amended 41 times since 2017-10-17; most recent amendment 2025-11-21.
Status change: Recruiting → Active, Not Recruiting 2023-09-12
Trial Details
NCT Number NCT03315910
Lead Sponsor Memorial Sloan Kettering Cancer Center
Collaborators: National Cancer Institute (NCI)
Conditions Smoking Cessation
Enrollment 807 participants
Start Date 2017-10-10
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-11-24